Chief Financial Officer (CFO) for $2B US Commercial Business Unit + Global Manufacturing Operations with full Income Statement, Balance Sheet, and Cash Flow responsibilities.Lead diverse, global Finance team (80+ employees) accountable for financial operations, productivity improvements, and transformation initiatives.

Chief Financial Officer (CFO) for $1.3B US Pet Health Business Unit with full Income Statement, Balance Sheet, and Cash Flow responsibilities. Lead diverse, global Finance team (30+ employees) accountable for financial operations, productivity improvements, and transformation initiatives.

Head of Corporate Financial Planning & Analysis for $4.5B Animal Health corporation. Led global team responsible for annual budgeting, forecasting, long-range strategic planning, and management reporting for broader enterprise.Supported stand-up of independent Elanco Finance organization as part of Initial Public Offering (IPO) – strong focus on capability development in conjunction with Finance Leadership Team (Treasury, Tax, Accounting, Investor Relations).

Finance Director for global Manufacturing organization with responsibility for Financial Planning & Analysis, Business Development, and cross-functional leadership team support.Supported development and implementation of $300M+ productivity agenda aimed at increasing operating margins by ~1,000 bps.Led global team of six finance professionals and invest in staff performance / development.

Led strategic initiatives for the $3B Elanco Animal Health Business Unit, including Business Plan, Strategic Plan, and business development activities related to the Novartis and Lohmann acquisitions. Managed monthly and quarterly financial closing process for global Business Unit, including management reporting to the Elanco Executive Team.

Managed global divestiture planning, including supply chain redesign and legal entity restructuring, for the Finance function as part of $13 billion carve-out of global Animal Health business. Led operating model restructuring, including strategic design and business case development, for manufacturing finance organization of $50 billion global Pharmaceutical organization, resulting in 10% annual net savings and greater process efficiency.Directed integration planning and execution initiatives, including synergy capture and organizational design, as part of $3 billion acquisition of global pharmaceutical company.Recognized as one of the top leaders within global peer group throughout 10 year tenure, and served on the National Manager and National Senior Consultant leadership teams.